Scolaris Content Display Scolaris Content Display

Opieka interkoncepcyjna nad kobietami z przebytą cukrzycą ciążową, której celem jest poprawa wyników zdrowotnych u matki i dziecka

Contraer todo Desplegar todo

Referencias

References to studies awaiting assessment

Koivusalo 2016 {published data only}

Grotenfelt NE, Wasenius NS, Rono K, Laivuori H, Stach‐Lempinen B, Orho‐Melander M, et al. Interaction between rs10830963 polymorphism in MTNR1b and lifestyle intervention on occurrence of gestational diabetes. Diabetologia 2016;59(8):1655‐8. CENTRAL
Huvinen E, Grotenfelt NE, Eriksson JG, Rono K, Klemetti MM, Roine R, et al. Heterogeneity of maternal characteristics and impact on gestational diabetes (GDM) risk ‐ Implications for universal GDM screening?. Annals of Medicine 2016;48(1‐2):52‐8. CENTRAL
Huvinen H, Koivusalo S, StachLempinen B, Kautiainen H, Eriksson J. Effects of a lifestyle intervention during pregnancy and 1‐year postpartum ‐ results from the RADIEL study. Gynecological Endocrinology 2016;32:161. CENTRAL
Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, et al. Gestational diabetes mellitus can be prevented by lifestyle intervention: The Finnish gestational diabetes prevention study (RADIEL): A randomized controlled trial. Diabetes Care 2016;39(1):24‐30. CENTRAL
Meinila J, Valkama A, Koivusalo SB, Rono K, Kautiainen H, Lindstrom J, et al. Association between diet quality measured by the healthy food intake index and later risk of gestational diabetes ‐ a secondary analysis of the RADIEL trial. European Journal of Clinical Nutrition 2017;71(4):555‐7. CENTRAL
NCT01698385. Prevention of gestational diabetes through lifestyle modification (RADIEL). clinicaltrials.gov/ct2/show/NCT01698385 Date first received: 11 September 2012. CENTRAL
Rono K, Stach‐Lempinen B, Klemetti MM, Kaaja RJ, Poyhonen‐Alho M, Eriksson JG, et al. Prevention of gestational diabetes through lifestyle intervention: study design and methods of a Finnish randomized controlled multicenter trial (RADIEL). BMC Pregnancy and Childbirth 2014;14:70. CENTRAL
Valkama A, Koivusalo S, Lindstrom J, Meinila J, Kautiainen H, Stach‐Lempinen B, et al. The effect of dietary counselling on diet in pregnant women at risk for gestational diabetes. Annals of Nutrition and Metabolism 2015;67(Suppl 1):138. CENTRAL
Valkama A, Koivusalo S, Lindstrom J, Meinila J, Kautiainen H, Stach‐Lempinen B, et al. The effect of dietary counselling on food intakes in pregnant women at risk for gestational diabetes: a secondary analysis of a randomised controlled trial RADIEL. European Journal of Clinical Nutrition 2016;70(8):912‐7. CENTRAL

ISRCTN76189107 {published data only}

ISRCTN76189107. A pre‐pregnancy study examining the effects of an intensive lifestyle package supported with Liraglutide treatment, a medication equivalent to a natural hormone produced in the stomach, in obese women with previous history of pregnancy diabetes. isrctn.com/ISRCTN76189107 Date first received: 21 December 2016. CENTRAL

NCT00924599 {published data only}

NCT00924599. Prevention of gestational diabetes pilot study. clinicaltrials.gov/show/NCT00924599 Date first received: 4 May 2009. CENTRAL

ACOG 2013

American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 137: Gestational diabetes mellitus. Obstetrics and Gynecology 2013;122(2 Pt 1):406‐16.

ADA 2017

American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care 2017;40(Suppl 1):S114‐9.

Alwan 2009

Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2]

Blatt 2011

Blatt AJ, Nakamoto JM, Kaufman HW. Gaps in diabetes screening during pregnancy and postpartum. Obstetrics and Gynecology 2011;117:61‐8.

Brown 2016a

Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2016, Issue 1. [DOI: 10.1002/14651858.CD012037]

Brown 2016b

Brown J, Crawford TJ, Alsweiler J, Crowther CA. Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes. Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/14651858.CD012048.pub2]

Brown 2017a

Brown J, Alwan NA, West J, Brown S, McKinlay CJD, Farrar D, Crowther CA. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2017, Issue 5. [DOI: 10.1002/14651858.CD011970.pub2]

Brown 2017b

Brown J, Martis R, Hughes B, Rowan J, Crowther CA. Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD011967.pub2]

Brown 2017c

Brown J, Ceysens G, Boulvain M. Exercise for pregnant women with gestational diabetes for improving maternal and fetal outcomes. Cochrane Database of Systematic Reviews 2017, Issue 6. [DOI: 10.1002/14651858.CD012202.pub2]

CDA 2013

Canadian Diabetes Association. 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: diabetes and pregnancy. Canadian Journal of Diabetes 2013;37(Suppl 1):S168–183.

Clark 2009

Clark HD, Graham ID, Karovitch A, Keely EJ. Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. American Journal of Obstetrics and Gynecology 2009;200:634.e1‐7.

Crowther 2005

Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 2005;352:2477‐86.

Dodd 2007

Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology 2007;47(4):307‐12.

Farrar 2015

Farrar D, Duley L, Medley N, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database of Systematic Reviews 2015, Issue 1. [DOI: 10.1002/14651858.CD007122.pub3]

Gaudier 1992

Gaudier FL, Hauth JC, Poist M, Corbet D, Cliver SP. Recurrence of gestational diabetes mellitus. Obstetrics and Gynecology 1992;80(5):755‐8.

Getahun 2010

Getahun D, Fassett MJ, Jacobsen SJ. Gestational diabetes: risk of recurrence in subsequent pregnancies. American Journal of Obstetrics and Gynecology 2010;203(5):467.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Hunt 2007

Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstetrics and Gynecology Clinics of North America 2007;34(2):173‐99.

IADPSG 2010

International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676‐82.

Jiwani 2012

Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. Journal of Maternal Fetal and Neonatal Medicine 2012;25(6):600‐10.

Kieffer 2006

Kieffer EC, Sinco B, Kim C. Health behaviours among women of reproductive age with and without a history of gestational diabetes mellitus. Diabetes Care 2006;29(8):1788‐93.

Kim 2002

Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25(10):1862‐8.

Kim 2007

Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 2007;30(5):1314‐9.

Kim 2007b

Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A, Walker EA. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007;30(9):2281‐6.

Kwak 2008

Kwak SH, Kim HS, Choi SH, Lim S, Cho YM, Park KS, et al. Subsequent pregnancy after gestational diabetes mellitus: frequency and risk factors for recurrence in Korean women. Diabetes Care 2008;31(9):1867‐71.

Landon 2009

Landon MB, Spong CY, Thorn E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine 2009;361(14):1339‐48.

Li 2017

Li J, Shepherd E, Hague W, Crowther CA, Middleton P. Interventions for preventing type 2 diabetes in women with previous gestational diabetes. Personal correspondence2017.

MacNeill 2001

MacNeill S, Dodds L, Hamilton DC, Armson BA, VandenHof M. Rates and risk factors for recurrence of gestational diabetes. Diabetes Care 2001;24(4):659‐62.

Major 1998

Major CA, deVeciana M, Weeks J, Morgan MA. Recurrence of gestational diabetes: who is at risk?. American Journal of Obstetrics and Gynecology 1998;179(4):1038‐42.

Martis 2016

Martis R, Brown J, Alsweiler J, Crawford TJ, Crowther CA. Different intensities of glycaemic control for women with gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD011624.pub2]

Metzger 2007

Metzger BE, Buchanan TA, Coustan DR, De Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the fifth international workshop‐conference on gestational diabetes mellitus. Diabetes Care 2007;30(Suppl 2):S251‐60.

Middleton 2014

Middleton P, Crowther CA. Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD009578.pub2]

Nankervis 2014

Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. ADIPS Consensus Guidelines for the Testing and Diagnosis of Hyperglycaemia in Pregnancy in Australia and New Zealand. http://adips.org/ (accessed 17 February 2017).

NICE 2015

National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. https://www.nice.org.uk/guidance/ng3 (accessed 17 February 2017).

Petry 2010

Petry CJ. Gestational diabetes: risk factors and recent advances in its genetics and treatment. British Journal of Nutrition 2010;104(6):775‐87.

Ratner 2008

Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi‐Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. Journal of Clinical Endocrinology and Metabolism 2008;93(12):4774.

Reece 2009

Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373(9677):1789‐97.

Reece 2010

Reece EA. The fetal and maternal consequences of gestational diabetes mellitus. Journal of Maternal‐Fetal and Neonatal Medicine 2010;23(3):199‐203.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Spong 1998

Spong CY, Guillermo MD, Kuboshige J, Cabalum T. Recurrence of gestational diabetes mellitus: identification of risk factors. American Journal of Perinatology 1998;15(1):29‐33.

Tieu 2010

Tieu J, Middleton P, Crowther C. Preconception care for diabetic women for improving maternal and infant health. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD007776.pub2]

Tieu 2010b

Tieu J, Coat S, Hague W, Middleton P. Oral anti‐diabetic agents for women with pre‐existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD007724.pub2]

Tieu 2014

Tieu J, Middleton P, McPhee AJ, Crowther CA. Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD007222.pub3]

Torloni 2009

Torloni M R, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta‐analysis. Obesity Reviews 2009;10(2):194‐203.

Toulis 2009

Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I, et al. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta‐analysis. Fertility and Sterility 2009;92(2):667‐77.

Vohr 2008

Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome?. Journal of Maternal, Fetal and Neonatal Medicine 2008;21(3):149‐57.

Whitworth 2009

Whitworth M, Dowswell T. Routine pre‐pregnancy health promotion for improving pregnancy outcomes. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007536.pub2]

WHO 1999

World Health Organization. Definition, diagnosis and classification of diabetes mellitus ‐ report of a WHO/IDF consultation. www.who.int/diabetes/publications/diagnosis_diabetes1999/en/index.html (accessed 25 July 2012).

References to other published versions of this review

Tieu 2012

Tieu J, Middleton P, Crowther CA 10.1002/14651858.CD010211. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD010211]

Tieu 2013

Tieu J, Bain E, Middleton P, Crowther CA. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010211.pub2]

Characteristics of studies

Characteristics of studies awaiting assessment [ordered by study ID]

Koivusalo 2016

Methods

Randomised controlled trial.

Participants

Inclusion criteria: women with a previous history of GDM or a pre‐pregnancy BMI ≥ 30 kg/m², either planning pregnancy or pregnant at < 20 + 0 weeks’ gestation.

Exclusion criteria: age < 18 years; diabetes diagnosed before pregnancy; medications that influence glucose metabolism (e.g. oral corticosteroids and metformin); multiple pregnancies; physical disability; current substance abuse; severe psychiatric disorders and significant difficulties to co‐operate (e.g. inadequate Finnish language skills).

Interventions

Women randomised to structured counselling on diet and exercise or standard care.

Diet and exercise intervention

Women visited the study nurse every 3 months before and during pregnancy, and at 6 weeks, 6 and 12 months postpartum. Trained study nurses and nutritionists provided counselling, as below, and weight targets were set: 5% to 10% weight loss before pregnancy for women with pre‐pregnancy BMI ≥ 25 kg/m²; no weight gain during the first 2 trimesters for women with pre‐pregnancy BMI ≥ 30 kg/m².

Dietary counselling was based on national Finnish nutritional guidelines. The 'plate model' was used during the counselling sessions (filling half a plate with raw/cooked vegetables, one quarter with starchy carbohydrates, and one quarter with meat, fish, beans, eggs or other proteins). The aim was to achieve a total energy intake of 1600‐1800 kcal/day; 40% to 50% from carbohydrates, 30% to 40% from fats, and 20% to 25% from protein. Women were encouraged to increase intake of vegetables, legumes, fruits and berries; wholegrain and fibre; low‐fat dairy and vegetable fats. In the postpartum period, women received breastfeeding and infant nutrition counselling based on national recommendations. Every 3 months women filled in 3‐day food diaries. In addition to regular visits to the study nurse, women took part in structured group visits to a nutritionist, at enrolment, during the first trimester and at 6 and 12 month postpartum; with additional visits arranged if needed.

The aim of the physical activity counselling was to achieve a minimum of 30 minutes of moderate intensity exercise (exercise during which the woman becomes at least slightly out of breath and perspires but is still able to talk) 5 times/week or 50 minutes 3 times/week, and to adopt an overall active lifestyle. An individual exercise program was planned for each woman during the counselling visits, and modified as needed. Women also received pedometers, with a recommendation of at least 10,000 steps/day. Women had the option of attending guided exercise groups, or got tickets (e.g. to public swimming pooled once a week. Physical activity logbooks were used.

Standard care

Women received basic dietary and exercise information leaflets similar to those provided at primary health care centres at the time of enrolment. During pregnancy, they received usual health education provided at their local antenatal clinic.

Outcomes

Primary outcome: GDM.

Notes

Funding: "This study was funded by the Ahokas Foundation, the Finnish Foundation for Cardiovascular Disease, Special State Subsidy for Health Science Research of Helsinki University Central Hospital, Samfundet Folkhälsan, The Finnish Diabetes Research Foundation, the State Provincial Office of Southern Finland, and The Social Insurance Institution of Finland. The funders have not had any role in designing or conducting the study; in the collection, management, analysis, or interpretation of the data; in the preparation, review, or approval of the manuscript; and in the decision to submit the manuscript for publication".

Declarations of interest: "No potential conflicts of interest relevant to this article were reported".

Between February 2008 and November 2011, 788 women were recruited into the study. 235 were non‐pregnant and 493 pregnant during the first study visit. In the non‐pregnant and pregnant groups, 79.6% (women = 187) and 40.4% (women = 199), respectively, had a history of previous GDM.

To date, results have only been published for the women who were pregnant during the first study visit.

Last correspondence with Saila Koivusalo 01/12/2016 indicated manuscript relating specifically to non‐pregnant women with a history of GDM has not yet been published.

BMI: body mass index
GDM: gestational diabetes mellitus

Characteristics of ongoing studies [ordered by study ID]

ISRCTN76189107

Trial name or title

An open‐label randomized trial of an intensive lifestyle package supported with Liraglutide treatment in obese, non‐pregnant women with previous history of Gestational Diabetes Mellitus.

Methods

Randomised controlled trial.

Participants

Inclusion criteria: severe obesity (BMI ≥ 35 kg/m²) without type 2 and with previous GDM (with or without insulin); willing to give written informed consent and to comply with the requirements of this study protocol; aged ≥ 18 years at baseline; planning a pregnancy within the next 1 to 2 years; negative pregnancy test; contraception during the study period.

Exclusion criteria: allergy/sensitivity to study medication; pregnant or breast feeding or considering becoming pregnant during the study period; medical disorder requiring medication other than stable hypertension, hypothyroidism, polycystic ovarian syndrome; ongoing abuse of alcohol or narcotics; family or personal history of multiple endocrine neoplasia type 2 or familial medullary thyroid carcinoma; personal history of non‐familial medullary thyroid carcinoma; history of acute or chronic pancreatitis; obesity induced by drug treatment; use of approved weight lowering pharmacotherapy; previous surgical treatment of obesity; history of major depressive disorder or suicide attempt; uncontrolled hypertension; unable to provide written informed consent.

Interventions

Intervention: a treatment package of an intensive lifestyle approach (including diet and physical activity advice) supported by a daily treatment of liraglutide for a period of 6 months.

Control: usual care.

Outcomes

Primary outcomes: proportion of eligible women who would agree to participate in the study; acceptability of women of taking daily liraglutide injections; proportion of women that complied with the study protocol and completed the study intervention.

Secondary outcomes: fasting glucose; glucose homeostasis (OGTT, HbA1c, HOMA‐IR); inflammatory markers (C‐reactive protein); weight loss; GDM and/or impaired glucose tolerance in a subsequent pregnancy.

Starting date

Overall: September 2016; recruitment: April 2017; planned end date: December 2020.

Contact information

Professor Fionnuala McAuliffe, UCD Perinatal Research Centre, Obstetrics and Gynaecology, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland

Phone: +353 1 6373216

Email: [email protected]

Notes

Target recruitment: 50.

Sponsor: Clinical Research Centre, University College Dublin.

NCT00924599

Trial name or title

A pilot study using weight loss and exercise to prevent recurring gestational diabetes in obese women.

Methods

Randomised controlled trial.

Participants

Inclusion criteria: 18 to 40 year old women; English or Spanish speaking; GDM in last pregnancy; BMI 30 to 40 kg/m²; 1 to 5 years since last pregnancy; non‐smoking; planning to have a baby but willing to use birth control during a 3‐month weight loss program.

Exclusion criteria: 3 or more miscarriages; history of infertility; type 1 or type 2 diabetes; any weight loss since last pregnancy (based on last pre‐pregnancy weight); history of major psychiatric illness, drug abuse, or unsafe dieting practices; history of bariatric surgery, major medical conditions that prohibit physical activity or dietary intervention.

Interventions

Weight loss and exercise: women attended sessions focused on healthy weight loss, healthy eating and exercise; weekly sessions for 12 weeks followed by monthly group meetings until conception; aimed for loss of 7% of body weight and increased physical activity to 2.5 hours per week.

Lifestyle education: women received education focusing on learning about healthy eating and healthy activity, stress reduction techniques, ways of increasing activity; once a month for 3 months, then once a month until conception.

Outcomes

Primary outcome: GDM not present in pregnancy.

Starting date

Start date: June 2009; study completion: June 2014. No manuscript identified as yet.

Contact information

Associate Professor, Suzanne Phelan, California Polytechnic State University‐San Luis Obispo.

Notes

Enrolment: 12 women.

Sponsor: California Polytechnic State University‐San Luis Obispo.

BMI: body mass index
GDM: gestational diabetes mellitus
HbA1c: glycated haemoglobin
HOMA‐IR: homeostatic model assessment ‐ insulin resistance
OGTT: oral glucose tolerance test

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.